GLSI
Greenwich Lifesciences Inc
Price:  
13.27 
USD
Volume:  
27,253.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GLSI WACC - Weighted Average Cost of Capital

The WACC of Greenwich Lifesciences Inc (GLSI) is 7.2%.

The Cost of Equity of Greenwich Lifesciences Inc (GLSI) is 10.65%.
The Cost of Debt of Greenwich Lifesciences Inc (GLSI) is 5.00%.

Range Selected
Cost of equity 7.40% - 13.90% 10.65%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.5% - 8.8% 7.2%
WACC

GLSI WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.76 1.61
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.40% 13.90%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.5% 8.8%
Selected WACC 7.2%